Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bioventus (BVS) Long-Term Debt Repayments (2020 - 2025)

Bioventus filings provide 6 years of Long-Term Debt Repayments readings, the most recent being $25.0 million for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 66.67% to $25.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.0 million, a 200.0% increase, with the full-year FY2025 number at $45.0 million, up 200.0% from a year prior.
  • Long-Term Debt Repayments hit $25.0 million in Q4 2025 for Bioventus, up from $10.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $25.0 million in Q4 2022 to a low of -$7.5 million in Q4 2021.
  • Median Long-Term Debt Repayments over the past 5 years was $10.0 million (2025), compared with a mean of $11.8 million.
  • Biggest five-year swings in Long-Term Debt Repayments: tumbled 116.13% in 2021 and later surged 433.33% in 2022.
  • Bioventus' Long-Term Debt Repayments stood at $20.0 million in 2021, then increased by 25.0% to $25.0 million in 2022, then crashed by 72.0% to $7.0 million in 2023, then skyrocketed by 114.29% to $15.0 million in 2024, then surged by 66.67% to $25.0 million in 2025.
  • The last three reported values for Long-Term Debt Repayments were $25.0 million (Q4 2025), $10.0 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.